111 EBITDA Margin 2018-2024 | YI
111 EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2024-06-30 | $2.05B | $-0.04B | -1.91% |
2024-03-31 | $2.06B | $-0.05B | -2.19% |
2023-12-31 | $2.11B | $-0.05B | -2.33% |
2023-09-30 | $2.09B | $-0.03B | -1.63% |
2023-06-30 | $2.05B | $-0.03B | -1.66% |
2023-03-31 | $2.03B | $-0.04B | -1.97% |
2022-12-31 | $1.96B | $-0.05B | -2.71% |
2022-09-30 | $1.96B | $-0.06B | -2.91% |
2022-06-30 | $2.01B | $-0.07B | -3.64% |
2022-03-31 | $2.02B | $-0.09B | -4.45% |
2021-12-31 | $1.95B | $-0.10B | -5.13% |
2021-09-30 | $1.84B | $-0.11B | -5.82% |
2021-06-30 | $1.67B | $-0.10B | -5.87% |
2021-03-31 | $1.43B | $-0.08B | -5.73% |
2020-12-31 | $1.26B | $-0.07B | -5.72% |
2020-09-30 | $0.99B | $-0.07B | -7.14% |
2020-06-30 | $0.80B | $-0.07B | -8.74% |
2020-03-31 | $0.69B | $-0.07B | -10.39% |
2019-12-31 | $0.57B | $-0.07B | -12.68% |
2019-09-30 | $0.45B | $-0.07B | -14.99% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.056B | $2.105B |
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $10.500B | 0.00 |
Hims & Hers Health (HIMS) | United States | $5.733B | 148.28 |
Inspire Medical Systems (INSP) | United States | $5.716B | 178.27 |
Axonics (AXNX) | United States | $3.603B | 1762.25 |
IRhythm Technologies (IRTC) | United States | $2.729B | 0.00 |
Privia Health (PRVA) | United States | $2.710B | 225.80 |
Enovis (ENOV) | United States | $2.621B | 17.77 |
Omnicell (OMCL) | United States | $2.264B | 74.08 |
Azenta (AZTA) | United States | $2.250B | 112.17 |
10x Genomics (TXG) | United States | $1.898B | 0.00 |
Schrodinger (SDGR) | United States | $1.620B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.617B | 0.00 |
Phreesia (PHR) | United States | $1.235B | 0.00 |
Standard BioTools (LAB) | United States | $0.763B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
Talkspace (TALK) | United States | $0.569B | 0.00 |
Definitive Healthcare (DH) | United States | $0.528B | 91.40 |
Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
Pulmonx (LUNG) | United States | $0.278B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.261B | 0.00 |
TruBridge (TBRG) | United States | $0.234B | 67.96 |
P3 Health Partners (PIII) | United States | $0.140B | 0.00 |
American Well (AMWL) | United States | $0.136B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.098B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
HeartBeam (BEAT) | United States | $0.063B | 0.00 |
CareCloud (CCLD) | United States | $0.051B | 0.00 |
Zepp Health (ZEPP) | China | $0.049B | 0.00 |
Outset Medical (OM) | United States | $0.045B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
Movano (MOVE) | United States | $0.028B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
MSP Recovery (LIFW) | United States | $0.017B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |